Table 1.
Patient ID | Patient gender | Patient age | Tumor histology* | Tumor size | Fuhrman grade | pTNM*** |
---|---|---|---|---|---|---|
SS052 | Male | 52 | RCC, clear cell | 2.5 cm | 2 | pT1a, pNX, pMX |
SS053 | Female | 62 | RCC, clear cell | 1.5 cm | 2 | pT1a, pNX, pMX |
SS054 | Male | 61 | RCC, papillary | 5.5 cm | 2 | pT1b, pNX, pMX |
SS055 | Male | 76 | RCC, clear cell and papillary | 1.0 cm, 0.4 cm** | 2 | pT1a, pNX, pMX |
SS056 | Male | 60 | RCC, clear cell and papillary | 8.4 cm | 3 | pT2a, pNX, pMX |
SS059 | Male | 72 | RCC, papillary | 10.6 cm, 1.2 cm** | 3 | pT2b, pNX, pMX |
SS060 | Male | 74 | RCC, clear cell | 10.2 cm | 3 | pT3a, pN1, pMX |
SS062 | Female | 53 | RCC, unclassified | 2.2 cm | 3 | pT1a, pNX, pMX |
SS063 | Male | 42 | RCC, chromophobe | 8.0 cm | 3 | pT2a, pNX, pMX |
SS064 | Male | 70 | Oncocytoma | 2.0 cm | n/a | n/a |
SS065 | Male | 52 | Cystic nephroma | 8.0 cm | n/a | n/a |
*RCC: renal cell carcinoma.
**Two measurements for the foci in a multicentric tumor.
*** pTNM: p: pathologic stage; T: primary tumor size; N: regional lymph node status; M: distant metastatic sites.